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OBJECTIVES: To analyze angiotomographic parameters of juxtarenal aneurysms to assess the applicability of an
endograft model to patients and to create in vitro and in vivo models to assess the new endograft.
METHODS: A total of 49 patients with juxtarenal aneurysms were submitted to angiotomographic evaluation,
and parameters such as the aortic diameter, the length of the neck, and the angulations of the celiac trunk,
superior mesenteric artery and renal arteries; the distances between them; and anatomic variations were
analyzed. Based on these parameters, an endograft model was developed and tested in a newly created in vitro
model of juxtarenal aneurysm. An experimental model of juxtarenal aneurysm was then established in six pigs
weighing 50–60 kg to assess the new endograft model.
RESULTS: The angiotomographic parameters of juxtarenal aneurysm measured in this study were similar to
those reported in the literature and allowed the development of an endograft based on the hourglass concept,
which was applicable to 85.8% of the patients. The in vitro model of juxtarenal aneurysm evidenced good
radiopacity and functionality and permitted adjustments in the new device and technical improvements in the
procedures for treating these aneurysms. In addition, the porcine model of juxtarenal aneurysm was successfully
created in all six animals using a bovine pericardial patch, and use of the new endograft in three pilot
procedures evidenced its feasibility.
CONCLUSIONS: The Hourglass endograft was rendered applicable to treatment of the majority of patients with
juxtarenal aneurysms simply by changing its diameter. Moreover, the new in vitro and in vivo models were
shown to be effective for assessing both the presented endograft and experiments assessing the endovascular
treatment of juxtarenal aneurysms.
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’ INTRODUCTION
Juxtarenal aneurysms (JRAs) are defined as short-necked
(o15 mm) infrarenal aortic aneurysms and comprise 15%
of all abdominal aortic aneurysms (1). For patients
younger than 65 years of age with low surgical risk, open
repair is considered the gold-standard treatment, and early
mortality ranges from 0% to 8.6%. Complications asso-
ciated with supra-renal clamping are reported in 3.1% to
6.1% of patients (2), and 0% to 3.8% of all patients require
permanent dialysis (3). Endovascular repair (EVAR) is
indicated for older patients and for those with severe
comorbidities or high surgical risk, and early mortality
ranges from 0.8% to 4.1% (4).
Endovascular procedures for the treatment of JRA include a
hybrid technique, fenestrated or branched endografts, and the
chimney technique (5) and are associated with more early and
late postoperative complications, and especially renal insuffi-
ciency, endoleaks and thrombosis of the stent (6). Certain
authors consider endovascular approaches to be contra-
indicated for JRA (4), but a recent systematic review (7)
comparing open and endovascular repair of JRA showed
promising results for EVAR, with significantly lower rates of
two-year mortality compared with open repair (16% and
23%, respectively). However, the rates remain higher than
those observed in infrarenal aneurysms with a neck length
415 mm (7.8%) (8).DOI: 10.6061/clinics/2015(06)09
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Conventional surgery for JRA remains associated with
high rates of morbidity and mortality. However, even for
well-selected patients, most fenestrated or branched endo-
grafts must be customized to each patient, resulting in very
difficult and expensive access to such technology. All of these
issues highlight the need for new endovascular devices that
are feasible for the treatment of JRA.
Based on this need, the objectives of the present study were as
follows: 1) to analyze the angiotomographic parameters of
patients with JRA; 2) to adjust a projected endograft model for
JRA repair based on the angiotomographic analysis, 3) to create
an in vitro model to assess the new endograft model, and 4) to
test the new endograft in a newly created porcine model of JRA.
’ METHODS
Angiotomographic parameters
Angiotomographies of 49 patients with JRA (neck length
o15 mm) treated between January 2009 and October 2013
were selected from the hospital registry, and the parameters
belowwere analyzed using OsiriX image-processing freeware.
Parameters included the aortic diameter of the celiac trunk
(CT), superior mesenteric artery (SMA), higher renal artery
(HRA) and lower renal artery (LRA); angulations of the CT,
SMA, right renal artery (RA), and left RA; longitudinal
distances between the CT and the SMA, between the SMA
and the HRA, and between the SMA and the LRA; and the
length of the neck.
Each patient’s angiotomographic parameters were
correlated using Pearson’s correlation coefficient. After
constructing a 95% confidence interval, descriptive measures
were analyzed using Student’s t test. Statistical observations
were used to assess the applicability of the projected endograft.
Projected endograft
The Hourglass endograft (Figure 1) was projected in
partnership with Braile Biomédica (São Paulo, Brazil) based
on several main principles, as follows:
 proximal free flow to increase the fixation area using an
uncovered stent;
 inner branching to gain external area and to allow
sufficient area for the apposition of a covered stent,
avoiding endoleaks;
 a distal area functioning as a longer ‘‘neo-neck’’ of the
aneurysm for overlap with a conventional endograft to
treat infrarenal aneurysms;
 a proximal anterior scallop (in a half-moon shape) to
maintain the patency of the SMA;
 hourglass-like narrowing (o35%) to create a good distance
between the endograft and the aortic wall, allowing easier
catheterization of the RAs, even if in different positions in
both the anteroposterior and the inferosuperior directions.
In vitro model of JRA
An in vitro model of JRA was designed, as shown in
Figure 2, and was manufactured using glass.
The projected endograft was tested in the in vitro model
while employing a hemodynamic procedure, using the same
Figure 1 - Features of the projected Hourglass endograft.
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materials as if treating a human being. After releasing the
Hourglass endograft, the covered stents (Viabhan-GOREs)
were placed in the RA, and a bifurcated endograft usually
used for the treatment of infrarenal aneurysms was placed to
complete the testing procedures (Figure 3). The functionality
and radiopacity of the model and its adherence to the
endograft material were then assessed.
Porcine model of JRA
An experimental model of JRA was created in six
domestic white pigs weighing 50 kg to 60 kg (R.G. Grange,
Mea Farm, Suzano, São Paulo, SP, Brazil). All pertinent
guidelines described by current Brazilian legislation (Decree
6,899/2009) on the use and protection of animals in experimental
research were rigorously followed, and this study was approved
by the Ethics Board in Scientific Research of the Medical School
of São Paulo University (protocol number 431/11).
Three pigs were used in a pilot experiment, and the
feasibility of the procedure, the catheterization of the RAs,
and the patency and pressure rates were assessed before and
after deploying the device. Based on this assessment, the
endograft was adapted to the porcine model with an external
covered fenestrated segment and was then placed in another
three pigs and again assessed (Figure 4).
The animals were submitted to pre-anesthesia with
intramuscular ketamine and midazolam. Anesthesia was
induced with intravenous thiopental and maintained with
continuous inhalation of halothane and intravenous fentanyl.
Physiological breathing parameters were maintained with
mechanical ventilation. Cardiac frequency, invasive arterial
pressure and central venous pressure were continuously
assessed until the animals were sacrificed.
’ RESULTS
The analysis of angiotomographic parameters revealed
significant positive correlations among aortic diameter
measurements at different locations (range: r=0.71 to
r=0.93) and between the longitudinal SMA-HRA and SMA-
LRA distances (r=0.59), indicating that variations in such
parameters in each patient followed a very homogeneous
pattern. No correlation was found for angulations or the
other longitudinal distances, and the individual patterns of
these variations were heterogeneous (Figure 5). Descriptive
measures for all 49 patients are presented in Table 1.
According to these findings, the projected endograft was
shown to be applicable in 85.8% of cases. The excluded cases
were as follows: one patient with only one kidney, three
patients presenting a polar artery, one patient with neck
angulation445 ˚ , one patient with SMA angulation435 ˚ , and
one patient with a longitudinal SMA-HRA distanceo0.40 cm.
The in vitro model of JRAwas shown to be functional and to
have good radiopacity and optimal adherence to the endograft
material, allowing adjustments of the projected endograft and
technical improvements in the endovascular procedures.
In three procedures simulating the treatment of JRA, with
durations of 42, 48 and 49 min, the covered stents were easily
catheterized and released in the RA.
A porcine model of JRA was successfully achieved in all
six pigs studied. The experimental procedures lasted 2 h
20 min, 1 h 55 min or 2 h 05 min and the necessary contrast
volumes were 85 ml, 110 ml and 120 ml, respectively. During
deployment of the adapted Hourglass endograft, difficult
catheterization of the RA resulted from the posteriorization
caused by the aneurysm model. The diameter prevented the
release of the distal bifurcated endograft. Thrombosis of one
covered stent was observed in the control angiogram, and
endoleaks were not observed. Moreover, no difference was
observed between the pressure rates measured before and
after deploying the endograft. Figure 6 illustrates the results
of the experimental procedure.
’ DISCUSSION
Conventional surgical treatment of JRA is a complex
procedure associated with more risks than surgical treatment
Figure 2 - Design of the in vitro model of juxtarenal aneurysm.
Figure 3 - Procedures for testing the Hourglass endograft in the
in vitro model of juxtarenal aneurysm: (1) proximal deployment
of the endograft; (2) RA catheterization; (3) final photographic
image of the in vitro experiment; (4) final fluoroscopic image of
the in vitro experiment.
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of infrarenal aneurysms, especially considering postopera-
tive renal morbidity. However, the success of endovascular
treatment of abdominal aortic aneurysms is dependent on
the site of proximal anchorage of the endograft, and
approximately 30% of the cases are not eligible for EVAR
with the currently available technologies because of unfavor-
able anatomy (6). Most recommendations refer to a proximal
neck length X15 mm for adequate proximal anchorage of
the endograft and cite proximal necks with a circumferential
mural thrombus or with severe angulation 460 ˚ as a
contraindication (5).
Several endovascular techniques have been developed in
an attempt to repair JRA. The hybrid technique combines
endograft deployment with occlusion of the entry of visceral
arteries previously revascularized with grafts. However, the
surgical stages are complex and long, causing significant
morbidity and very variable results (9). In the chimney
technique, the stent is placed through the external part of the
endograft to pass through the vessel and restore the visceral
flow, but such presentation of the stent in parallel with the
endograft can result in endoleaks and in stenosis or occlusion
of the stent (10).
Fenestrated and branched endografts were developed in an
attempt to increase the use of endografts by possibly moving
the anchorage area proximally to the RA; both types of
endografts could be customized based on imaging studies (10)
but were expensive and require an extended period of time
to be customized and prepared, delaying repair and thus
limiting their use (9). In most cases, catheterization of the
visceral branches through the orifices or branches repre-
sented a critical challenge, requiring considerable time and
effort, even for expert surgeons. Such difficulty has been
minimized with the use of new endografts developed to be
deployed through guide wires, which have previously been
used to catheterize the visceral vessels (11). Furthermore, the
success of deploying fenestrated and branched endografts is
dependent on the planned placement of the orifices or
branches because there is wide variation in the anatomy of
the visceral arteries emerging at the aorta. Considering the
most ventral point of the aorta to be at 12:00, a scallop fixed
at 12:00 for the SMA, fenestration for the left RA oscillating
between 9:15 and 10:15, and fenestration for the right RA
oscillating between 2:15 and 3:15 have already been observed
in a set of 439 customized endografts (12). The distance
between the origin of the orifice of the RA and the proximal
end of the endograft ranged from 19 mm to 28 mm.
Although such data were collected while developing
customized endografts (12), they also indicate the usefulness
of measuring certain parameters in a large number of
angiotomographies to characterize the emergence of visceral
arteries at the aorta and to thus aid the development of new,
more adequate endografts to be used in the treatment of JRA.
Figure 4 - Hourglass endograft adapted for placement in the porcine model of juxtarenal aneurysm (left) and images of an aortography
in one pig (right).
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The Hourglass endograft presented in the present study
was projected without requiring the proximal neck for its
fixation. For this purpose, the endograft had a proximal
scallop at 12:00 for the SMA and two small inner branches
for the RA, with lateral exits for the deployment of covered
stents. Considering the variations in the positions of RA
emergences, the endograft was hourglass shaped in the
small-branch segments to allow angulation of the covered
stent that catheterized the RA.
The angiotomographic parameters evaluated in this study
were consistent with those reported in the literature. Regarding
the angulation of the origin of the visceral arteries, Ferreira et al.
(13) reported similar measures when developing 21 branched
stent grafts for the repair of thoracoabdominal aneurysms in
high-risk patients. The longitudinal CT-SMA and SMA-HRA
distances in the current study were also very similar to those
reported by Takahashi et al. (14) in a study using 20 cadavers to
clarify the positional relationships between the CT, the SMA,
and the RA. Using these parameters, we confirmed the
applicability of the Hourglass endograft in 85.8% of the 49
patients with JRA who were submitted to angiotomographic
assessment.
The in vitro model created specifically to test and adjust the
Hourglass endograft seems to be the first reported model of
JRA in glass. Several authors have already reported the use of
an aortic model in glass in studies regarding staged endovas-
cular treatment for complicated type B dissection (15), flow
velocity and turbulence in the transverse aorta of a
proximally directed aortic cannula (16), staged proximal
deployment of thoracic stent grafts (17), the experimental
fluid dynamics of transventricular apical aortic cannulation
(18), and the hydrodynamics of aortic cannulas during
extracorporeal circulation (19). Berger et al. (20) also
proposed a dry glass model of the abdominal aorta and its
tributaries with various stenoses, elongations, and tortuos-
ities, named the STRESS machine, to test the endovascular
skills of vascular surgeons.
Using a glass model of JRA that was created to test the
Hourglass endograft, covered stents were easily catheterized
and released in the RA in the current study. The functionality
and radiopacity of this glass model and its optimal
adherence to the endograft material allowed for certain
adjustments to the Hourglass endograft, indicating its
usefulness in making future technical improvements in
endovascular procedures.
The development of a new endograft requires in vivo
assessment. Several techniques for creating experimental
aneurysms in vivo have been reported in the literature,
including genetic induction, interposition graft use, trans-
luminal dilatation, and infusion of substances such elastase.
Patch deployment is the most frequently used model because
it is simple to perform, fast and secure (21,22). To date,
however, we have not found any published reports regard-
ing models of JRA or thoracoabdominal aneurysms.
The porcine model of JRA presented here was developed
to assess the Hourglass endograft and was successfully
implemented in six animals, and the feasibility of the
endograft was demonstrated (Figure 6). Deployment of the
Figure 5 - Illustrative representation of the dispersive measures
of the angiotomographic parameters of 49 patients with
juxtarenal aneurysm.
Figure 6 - Images of the experimental treatment of an in vivo porcine model of juxtarenal aneurysm with the Hourglass endograft.
439
CLINICS 2015;70(6):435-440 New endograft for juxtarenal aneurysms
Belczak SQ et al.
new endograft occurred with certain expected difficulties
related to porcine anatomy, but endoleaks were not observed
in the imaging studies. Thrombosis of a covered stent was
also observed in the control angiogram in one case.
The development of the Hourglass endograft allowed us to
create feasible in vitro and in vivo models of JRA. Because
the angiotomographic parameter analysis revealed the
applicability of this endograft to more than 80% of the
patients involved in the study, the next steps include more
in vitro testing using a pressurized system and assessment of
both its feasibility and potential technical improvements in
the procedure using cadavers. After such analysis, a protocol
will be developed for use in human beings, affording the
opportunity to treat patients with JRA in a faster, cheaper
and more secure way.
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Table 1 - Descriptive measures of the angiotomographic parameters of 49 patients with juxtarenal aneurysm.
Parameter Descriptive measures
Minimum Maximum Mean Standard deviation Median
Aortic diameters CT 1.38 3.11 2.55 0.40 2.62
SMA 1.40 3.12 2.41 0.41 2.45
RMA 1.41 3.01 2.34 0.44 2.32
RMB 1.36 2.99 2.34 0.43 2.41
Angulations CT 1.72 351.28 29.64 48.34 24.11
SMA 1.10 352.24 64.08 117.42 18.48
Right RA 266.77 321.97 296.03 12.79 292.63
Left RA 36.89 137.66 89.72 21.77 94.34
Longitudinal distances CT-SMA 0.40 2.70 1.45 0.51 1.40
SMA-HRA 0.17 2.20 1.15 0.46 1.20
SMA-LRA 0.30 2.91 1.74 0.47 1.70
Length of neck 0.01 1.41 0.70 0.42 0.73
JRA: juxtarenal aneurysm; CT: celiac trunk; SMA: superior mesenteric artery; HRA: higher renal artery; LRA: lower renal artery; RA: renal artery.
440
New endograft for juxtarenal aneurysms
Belczak SQ et al.
CLINICS 2015;70(6):435-440
